Patents by Inventor Daniel James Catanese, JR.

Daniel James Catanese, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100189
    Abstract: MiniVectors and compositions containing MiniVectors that target genes implicated in IPF selected from CDH11, STAT3, STAT6, FoxM1, MDM2, TGF?, SMAD, PDGFA, or TLR4 and/or increase intracellular levels of reduced glutathione, relaxin, and p53, are provided, along with uses in the treatment of idiopathic pulmonary fibrosis.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 28, 2024
    Applicants: Twister Biotech, Inc, Baylor College of Medicine
    Inventors: E. Lynn ZECHIEDRICH, Lirio Milenka AREVALO-SOLIZ, Daniel James CATANESE, JR., Jonathan Marcus FOGG, Christopher E. COKER
  • Publication number: 20230190955
    Abstract: Compositions containing MiniVectors and gene therapy uses, including long term repeated gene therapy uses, to treat liver fibrosis or liver cancer.
    Type: Application
    Filed: October 20, 2022
    Publication date: June 22, 2023
    Applicants: BAYLOR COLLEGE OF MEDICINE, TWISTER BIOTECH, INC.
    Inventors: E. LYNN ZECHIEDRICH, LIRIO MILENKA AREVALO-SOLIZ, Daniel James CATANESE, JR., Jonathan Marcus FOGG, Christopher E. COKER, SANDEEP AGARWAL
  • Publication number: 20200048716
    Abstract: MiniVectors and compositions containing MiniVectors that target ovarian cancer genes selected from FOXM1, AKT, CENPA, PLK1, CDC20, BIRC5, AURKB, CCNB1, CDKN3, BCAM-AKT2, CDKN2D-WDFY2, SLC25A6, CIP2A, CD133, ALDH1A1, CD44, SALL4, and/or PRDM16, alone or in any combination, are provided, along with uses in the treatment of ovarian cancer.
    Type: Application
    Filed: November 5, 2018
    Publication date: February 13, 2020
    Inventors: E. Lynn Zechiedrich, Martin M. Matzuk, Laising Yen, Zhifeng Yu, Lirio Milenka Arevalo-Soliz, Daniel James Catanese, JR., Jonathan Marcus Fogg, Christopher Elbert Coker
  • Patent number: 9267150
    Abstract: The present invention relates to nucleic acid molecule compositions comprising minivectors encoding a nucleic acid sequence and methods of gene therapy using minivectors encoding a nucleic acid sequence.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: February 23, 2016
    Assignee: BAYLOR COLLEGE OF MEDICINE
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, Jr., Erol Bakkalbasi, Brian E. Gilbert
  • Publication number: 20150376645
    Abstract: In some embodiments the present disclosure provides a composition for targeted alteration of a DNA sequence and methods of altering the targeted DNA sequence using the composition. In some embodiments such a composition comprises a MiniVector comprising a nucleic acid sequence template for homology-directed repair, alteration, or replacement of the targeted DNA sequence within a cell in vivo or in vitro, where the MiniVector lacks both a bacterial origin of replication and an antibiotic selection gene, and wherein the Mini Vector has a size up to about 2,500 base pairs.
    Type: Application
    Filed: May 30, 2013
    Publication date: December 31, 2015
    Applicants: BAYLOR COLLEGE OF MEDICINE, UNIVERSITY OF WASHINGTON CENTER FOR COMMERCIALIZATION
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, JR., Nancy Maizel, Olivier Humbert
  • Patent number: 8729044
    Abstract: The present invention relates to nucleic acid molecule compositions comprising MiniVectors™ encoding a nucleic acid sequence and methods of gene therapy using MiniVectors encoding a nucleic acid sequence.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: May 20, 2014
    Assignee: Baylor College of Medicine
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, Jr., Erol Bakkalbasi, Brian E. Gilbert
  • Publication number: 20140056868
    Abstract: In some embodiments the present disclosure provides a composition for targeted alteration of a DNA sequence and methods of altering the targeted DNA sequence using the composition. In some embodiments such a composition comprises a MiniVector comprising a nucleic acid sequence template for homology-directed repair, alteration, or replacement of the targeted DNA sequence within a cell in vivo or in vitro, where the MiniVector lacks both a bacterial origin of replication and an antibiotic selection gene, and wherein the MiniVector has a size up to about 2,500 base pairs.
    Type: Application
    Filed: May 30, 2013
    Publication date: February 27, 2014
    Applicants: University of Washington Center for Commercialization, Baylor College of Medicine
    Inventors: Lynn E. Zechiedrich, Jonathan Fogg, Daniel James Catanese, JR., Erol Bakkalbasi, Nancy Maizel, Olivier Humbert
  • Patent number: 8460924
    Abstract: The present invention relates to nucleic acid molecule compositions comprising MiniVectors™ encoding a nucleic acid sequence and methods of gene therapy using MiniVectors encoding a nucleic acid sequence.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: June 11, 2013
    Assignee: Baylor College of Medicine
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, Jr., Erol Bakkalbasi, Brian E. Gilbert
  • Publication number: 20120302625
    Abstract: The present invention relates to nucleic acid molecule compositions comprising minivectors encoding a nucleic acid sequence and methods of gene therapy using minivectors encoding a nucleic acid sequence.
    Type: Application
    Filed: October 15, 2010
    Publication date: November 29, 2012
    Applicant: BAYLOR COLLEGE OF MEDICINE
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, JR., Erol Bakkalbasi, Brian E. Gilbert
  • Publication number: 20110160284
    Abstract: The present invention relates to nucleic acid molecule compositions comprising minivectors encoding a nucleic acid sequence and methods of gene therapy using minivectors encoding a nucleic acid sequence.
    Type: Application
    Filed: October 15, 2010
    Publication date: June 30, 2011
    Inventors: E. Lynn Zechiedrich, Jonathan Fogg, Daniel James Catanese, JR., Erol Bakkalbasi, Brian E. Gilbert